桂哌齐特联合血塞通治疗缺血性脑血管病的效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (37 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the effect of Guipazide combined with Xuesaitong in the treatment of ischemic cerebrovascular disease.Methods Ninety patients with ischemic cerebrovascular disease treated in Department of Neurology of our hospital from February 2018 to February 2019 were selected as subjects.They were divided into two groups according random number table method.The control group was treated with routine drugs.On this basis, the observation group was treated with Guipazide combined with Xuesaitong.The clinical efficacy, the changes of hemorheological indexes, the degree of neurological deficit and the ability of daily living and the levels of serum inflammatory factors in the two groups were compared.Results The total effective rate of treatment in the observation group was 95.56%,which was higher than 77.78% in the control group (P<0.05).After treatment, the plasma viscosity, whole blood high shear viscosity, whole blood low shear viscosity, fibrinogen and specific volume of blood cells in the observation group were lower than those in the control group (P<0.05).After treatment, the National Institute of Health stroke scale(NIHSS) score of the observation group was lower than that of the control group, while the Barthel index of the observation group was higher than that of the control group (P<0.05).The levels of hypersensitivity C-reactive protein (hs-CRP), homocysteine (Hcy), tumor necrosis factor-α (TNF-α) in the observation group were lower than those in the control group, the level of IL-10 (IL-10) was higher than that of the control group (P<0.05).Conclusion The clinical effect of Guipiazide combined with Xuesaitong in the treatment of ischemic cerebrovascular disease is remarkable, which can effectively improve blood viscosity, inhibit platelet aggregation, improve cerebral blood circulation, reduce the level of inflammatory factors and repair damaged nerve function.

Key words： Ischemic cerebrovascular disease Guipazide Xuesaitong Clinical effect

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	QIN Xiao-xia
	ZHANG Zhao-yong
	LIANG Zeng-bing

Cite this article:

QIN Xiao-xia,ZHANG Zhao-yong,LIANG Zeng-bing. Effect of Guipazide combined with Xuesaitong in the treatment of ischemic cerebrovascular disease[J]. 中国当代医药, 2020, 27(12): 136-138转162.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I12/136

[1]	罗世炜，林梦罴，林育微.血管内支架置入术联合马来酸桂哌齐特治疗缺血性脑血管病的临床效果[J].中国实用神经疾病杂志，2016，19（10）：76-77.
[2]	卢丹，阮海林.血塞通联合阿司匹林治疗缺血性脑血管病的疗效观察[J].广西医科大学学报，2017，34（3）：417-420.
[3]	刘桂周.奥扎格雷钠联合桂哌齐特治疗对动脉硬化性脑梗死患者血液流变学和血脂的影响及临床疗效[J].中国现代医药杂志，2017，19（1）：61-63.
[4]	中华神经科学会，中华神经外科学会.脑血管疾病分类（1995）[J].中华神经科杂志，1996，29（6）：376.
[5]	王莉，杨锋.小剂量川芎嗪联合血塞通注射液治疗缺血性脑血管疾病疗效及对血清CRP、Hcy 含量的影响[J].现代中西医结合杂志，2018，27（16）：1808-1810.
[6]	孙彩丽，张璐璐，杨旭，等.益气化瘀经验汤剂联合血塞通粉针治疗气虚血瘀证缺血性脑卒中患者的临床研究[J].世界中医药，2016，11（9）：1714-1717.
[7]	郭东青.血塞通联合西医抗血小板治疗脑梗死患者的疗效及对血脂代谢的影响[J].中国实用神经疾病杂志，2016，19（19）：84-85.
[8]	杨明华，樊素娟.血塞通注射液联合倍他司汀治疗后循环性缺血眩晕的疗效观察[J].现代药物与临床，2017，32（5）：784-787.
[9]	李小裴，周盛年.马来酸桂哌齐特联合尤瑞克林治疗急性脑梗死的疗效及对血液流变学和血清IL-10、TNF-α、hs-CRP 的影响[J].中西医结合心脑血管病杂志，2018，16（6）：785-788.
[10]	陈丽，耿飞，周洪胜.脑蛋白水解物对缺血性脑血管病患者FMD 水平及血液流变学的影响[J].淮海医药，2018，36（5）：578-580.
[11]	王倩.马来酸桂哌齐特注射液对后循环缺血患者的血液流变学和血流动力学的影响[J].中国实用神经疾病杂志，2016，19（13）：47-49.
[12]	潘昆仑.马来酸桂哌齐特治疗急性脑梗死的疗效及对血液流变学的影响[J].中国实用神经疾病杂志，2014，17（20）：24-26.
[13]	林腊鹏.舒血宁联合马来酸桂哌齐特治疗急性脑梗死的临床疗效[J].齐齐哈尔医学院学报，2017，38（7）：799-800.
[14]	刘柳，蒋超，王颖颖，等.血塞通胶囊对老年缺血性脑血管病患者颈动脉粥样硬化软斑块及血液流变学的影响[J].中国老年学杂志，2017，37（18）：4524-4526.
[15]	钟乐.马来酸桂哌齐特结合血塞通治疗老年腔隙性脑梗塞96例临床观察[J].中国初级卫生保健，2017，31（3）：78-79.